drugset / Trial / NCT05961956
Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis
NaSingle-groupOpen-labelTreatment
Summary
Prospective, single arm, single-center clinical study to test NVDX3 in patients suffering from low grade one level degenerative lumbar (L1 - S1) spondylolisthesis. NVDX3 will be implanted during a single surgical intervention.
Timeline
- Start
- 2023-10-12
- Primary completion
- 2026-04-18
- Completion
- 2026-04-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NVDX3 | Other / unclassified | — | Other |